The MSK expert discusses exciting advancements in the field of immunotherapy for treating lung cancer at the Annual New York Lung Cancers Symposium®.
Kathryn Arbour, MD
Advertisement
Articles by Kathryn Arbour, MD
Advertisement
Latest Updated Articles
Kathryn Arbour, MD, on the Development of KRAS G12C Inhibitors in Lung CancerPublished: November 19th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
2
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
3
Muscle RNome Analysis Reveals 2 Molecular Subtypes Associated With Cancer Cachexia
4
Short-Course Radiation May Be Feasible in Older Rectal Cancer Population
5
